Basic & Clinical Medicine ›› 2025, Vol. 45 ›› Issue (7): 974-980.doi: 10.16352/j.issn.1001-6325.2025.07.0974
• Guideline Interpretation • Previous Articles
LI Yingxia1#, LI Wenming1#, YU Qiuhua2, WU Nan2*
Received:
2025-02-22
Revised:
2025-04-17
Online:
2025-07-05
Published:
2025-06-24
Contact:
*1516846464@qq.com
CLC Number:
LI Yingxia, LI Wenming, YU Qiuhua, WU Nan. Interpretation on the Chinese Clinical Practice Guidelines for Hypertension: Key points of nursing practice and management strategies[J]. Basic & Clinical Medicine, 2025, 45(7): 974-980.
[1] | NCD Risk Factor Collaboration (NCD-RisC).Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019:a pooled analysis of 1201 population-representative studies with 104 million participants[J]. Lancet,2021,398:957-980. |
[2] | The Writing Committee of the Annual Report on Cardiovascular Health and Diseases in China.Interpretation of the annual report on cardiovascular health and diseases in China 2022[J]. Cardiol Discov,2024,4:5880. |
[3] | 中华医学会心血管病学分会,海峡两岸医药卫生交流协会高血压专业委员会,中国康复医学会心血管疾病预防与康复专业委员会.中国高血压临床实践指南[J]. 中华心血管病杂志,2024,52:985-1032. |
[4] | 娄莹,蔡军.防线前移 时不我待:中国高血压积极防控的时代已来[J]. 协和医学杂志,2024,15:1238-1241. |
[5] | Chen H,Cui Z,Lu W,et al.Geographical,sex,age,and seasonal differences in serum manganese status among Chinese adults with hypertension[J]. Biol Trace Elem Res,2023,201:41-50. |
[6] | Dumitrascu-Biris D, Nzelu D, Dassios T,et al.Chronic hypertension in pregnancy stratified by first-trimester blood pressure control and adverse perinatal outcomes:a prospective observational study[J]. Acta Obstet Gynecol Scand,2021,100:1297-1304. |
[7] | 马丽媛,王增武,樊静,等.《中国心血管健康与疾病报告 2021》关于中国高血压流行和防治现状[J]. 中国全科医学,2022,25:3715-3720. |
[8] | 陈磊,张鑫,叶润宇,等.高血压靶器官损害评估新进展[J]. 中华高血压杂志,2021,29:1002-1009. |
[9] | Kadomatsu Y, Tsukamoto M, Sasakabe T,et al.A risk score predicting new incidence of hypertension in Japan[J]. J Hum Hypertens,2019,33:748-755. |
[10] | McEvoy JW, McCarthy CP, Bruno RM,et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension[J]. Eur Heart J,2024,45:3912-4018. |
[11] | Mancia G, Kreutz R, Brunström M,et al.2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension:Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)[J]. J Hypertens,2023,41:1874-2071. |
[12] | 娄莹,马文君,王子君,等.中国高血压临床实践指南计划书[J]. 中华心血管病杂志,2022,50:671-675. |
[13] | Balshem H, Helfand M, Schünemann HJ,et al. GRADE guidelines: 3. Rating the quality of evidence[J]. J Clin Epidemiol,2011,64:401-406. |
[14] | The State Council.State council measures to enhance people′s fitness,health[EB/OL]. (2019-07-15)[2024-09-20]. http://english.www.gov.cn/policies/latestreleases/20190715/contentWS5d2c6f8fc6d05cbd94d67a02.html. |
[15] | 中华医学会心血管病学分会,中国康复医学会心脏预防与康复专业委员会,中国老年学和老年医学会心脏专业委员会,等.中国心血管病一级预防指南[J]. 中华心血管病杂志,2020,48:1000-1038. |
[16] | Li J,Zhao D,Cai J,et al.Cost-effectiveness of treatment inadults with blood pressure of 130-139/80-89 mmHg andhigh cardiovascular risk in China:a modelling study[J]. Lancet Reg Health West Pac,2023:100962.doi:10.1016/j.lanwpc.2023.100962. |
[17] | 张丽娟,刘敏,李志娟,等.诊室血压波动的影响因素及不同测量方法对血压分级的影响[J]. 郑州大学学报(医学版),2022,57:400-405. |
[18] | 中国老年医学学会高血压分会,国家老年疾病临床医学研究中心中国老年心血管病防治联盟.中国老年高血压管理指南2019[J]. 中华老年病研究电子杂志, 2019, 6:1-27. |
[19] | Viera AJ,Yano Y,Lin FC,et al. Does this adult patient have hypertension?:the rational clinical examination systematic review[J]. JAMA,2021,326:339-347. |
[20] | 蒋弼瀛,黄佳宇,陈文佳.肿瘤相关高血压的血压管理的研究进展[J]. 心血管病学进展,2024,45:52-56. |
[21] | Juhanoja EP, Puukka PJ, Johansson JK,et al.The impact of the day of the week on home blood pressure:the Finn-Home study[J]. Blood Press Monit,2016,21:63-68. |
[22] | Fu J,Liu Y,Zhang L,et al.Nonpharmacologic Interven-tions for reducing blood pressure in adults with prehypertension to established hypertension[J]. J Am Heart Assoc,2020,9:e016804. doi: 10.1161/JAHA.120.016804. |
[23] | Krishnamoorthy Y, Nagarajan R, Murali S.Effectiveness of multiple combined lifestyle interventions in reducing blood pressure among patients with prehypertension and hypertension:a network Meta-analysis[J]. J Public Health (Oxf),2023,45:e319-e331. |
[24] | 国家卫生健康委员会.中国居民营养与慢性病状况报告(2020年)[J]. 营养学报,2020,42:521. |
[25] | Hanssen H, Boardman H, Deiseroth A,et al.Personalizedexercise prescription in the prevention and treatment ofarterial hypertension:a consensus document from theEuropean Association of Preventive Cardiology (EAPC)and the ESC Council on Hypertension[J]. Eur J Prev Cardiol,2022,29:205-215. |
[26] | Wu Y, Johnson BT, Chen S, et al. Tai Ji Quan as antihypertensive lifestyle therapy: a systematic review and Meta-analysis[J]. J Sport Health Sci,2021,10:211-221. |
[27] | Zhang P, Zhang D, Lu D. The efficacy of Tai Chi for essential hypertension: a systematic review and Meta-analysis[J]. Int J Nurs Pract,2024,30:e13211. doi: 10.1111/ijn.13211. |
[28] | Ma J, Ma L, Lu S, et al. The effect of traditional Chinese exercises on blood pressure in patients with hypertension: a systematic review and Meta-analysis[J]. Evid Based Complement Alternat Med,2023,2023:2897664.doi:10.1155/202312897664. |
[29] | Zhu Z, Yan W, Yu Q, et al. Association between exercise and blood pressure in hypertensive residents: a Meta-analysis[J]. Evid Based Complement Alternat Med, 2022,2022:2453805. |
[30] | Global BMI Mortality Collaboration, Di Angelantonio E, Bhupathiraju ShN, et al.Body-mass index and all-cause mortality:individual-participant-data meta-analysis of 239 prospective studies in four continents[J]. Lancet,2016,388:776-786. |
[31] | 中华医学会内分泌学分会肥胖学组.中国成人肥胖症防治专家共识[J]. 中华内分泌代谢杂志,2011,27:711-717. |
[32] | 王增武.《中国高血压防治指南(2024年修订版)》更新要点解读[J]. 中国心血管杂志,2024,29:391-395. |
[33] | Mackenzie IS, Rogers A, Poulter NR, et al. Cardiovas-cular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial[J]. Lancet, 2022, 400: 1417-1425. |
[1] | LI Danying, GUO Xiaojing, ZHU Xiaolei, SI Xiang, ZHANG Xiaochang, WAN Xia. Identifying key factors of hypertension control using Bayesian networks in the 2021—2022 National Basic Public Health Service Project [J]. Basic & Clinical Medicine, 2025, 45(7): 926-932. |
[2] | DUAN Wenxin, SONG Wanlu, YANG Peiran, WANG Jing. Progress on omics studies of chronic thromboembolic pulmonary hypertension [J]. Basic & Clinical Medicine, 2025, 45(7): 963-968. |
[3] | LU Xiaoxuan, GUO Lina, ZHANG Hong, SONG Wanlu, HU Yufei, YANG Peiran. Endothelial cell proliferation and extracellular matrix-related pathways regulate pulmonary arterial hypertension in rat models [J]. Basic & Clinical Medicine, 2025, 45(6): 770-776. |
[4] | WANG Rui, ZHANG Yuping, LI Rui, LI Yunlong, LI Yuan, ZHANG Yuan, LIU Yanping. Blood glucose fluctuations are associated with the onset of gestational hypertension in gestational diabetes mellitus patients [J]. Basic & Clinical Medicine, 2025, 45(5): 664-670. |
[5] | ZHANG Junshi, LIU Haiming, CHEN Xi. Vitamin D reduces inflammatory response in hypertensive mice with early renal injury [J]. Basic & Clinical Medicine, 2025, 45(2): 176-182. |
[6] | ZHANG Zongli, LI Tao, MA Jingwen, ZHANG Jiaxin, LI Xingchao, XI Shibing. Impact of oxygen concentration changes on ANGPTL8 expression of human pulmonary artery endothelial cells [J]. Basic & Clinical Medicine, 2025, 45(1): 12-19. |
[7] | HU Song, HUA Lu, ZHANG Jian. Anti-coagulation therapy for pulmonary hypertension: necessity and dilemmas [J]. Basic & Clinical Medicine, 2024, 44(8): 1062-1067. |
[8] | DENG Yuanrui, WANG Xiaojian. Metabolomics of pulmonary hypertension: from pathological mechanisms to therapeutic targets [J]. Basic & Clinical Medicine, 2024, 44(8): 1074-1079. |
[9] | QIAN Xifeng, HUA Lu. Inflammatory cells and vascular remodeling in pulmonary arterial hypertension [J]. Basic & Clinical Medicine, 2024, 44(8): 1080-1087. |
[10] | GAO Yidan, JIANG Xuehan, ZHANG Hong, YANG Peiran. Development of novel therapies targeting at dysregulated signaling pathways in pulmonary arterial hypertension [J]. Basic & Clinical Medicine, 2024, 44(8): 1088-1093. |
[11] | FU Zhigang, QIN Jia, TAN Jiangshan. Portopulmonary hypertension: advances and challenges in diagnosis and clinical treatment [J]. Basic & Clinical Medicine, 2024, 44(8): 1068-1073. |
[12] | HAN Lijie, HU Chaowei, YU Huahui, QIN Yanwen. Research progress on the roles of angiopoietin-like protein 8 in the pathogenesis of cardiovascular diseases [J]. Basic & Clinical Medicine, 2024, 44(4): 544-547. |
[13] | YANG Tong, XU Yuan, PU Xingyun, MA Yiting, YANG Jing, SHU Xin, PENG Hongyu, WU Yanrui, LONG Li. Correlation between interleukin 1β-511C/T polymorphism and essential hypertension in the Yi ethnic group of Yunnan province [J]. Basic & Clinical Medicine, 2024, 44(12): 1651-1655. |
[14] | WEN Haixiu, GAO Shuhong, LI Shufeng. Effects of sleep duration and body mass index on hypertension [J]. Basic & Clinical Medicine, 2024, 44(12): 1628-1632. |
[15] | JIANG Chenchen, CUI Ze, PAN Li, SUN Jixin, HE Huijing, HU Yaoda, SHAN Guangliang. Interaction of family history of hypertension and overweight/obesity on hypertension in Han and Manchu adults in Hebei province [J]. Basic & Clinical Medicine, 2023, 43(7): 1053-1059. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||
Full text 12
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Abstract 79
|
|
|||||||||||||||||||||||||||||||||||||||||||||